Streptokinase was infused in a patient for the management of deep vein thrombosis, following which the patient developed hematemesis. Which of the given agents can be chosen to manage this episode of hematemesis?: (A) Vitamin K, (B) Noradrenaline, (C) Epsilon amino caproic acid, (D) Rutin
Answer is C. Tranexamic acid and EACA are antifibrinolytic drugs which are used as antidotes for the management of fibrinolytic drug poisoning.